- Why Research
- Our Impact
- Get Involved
- About BCRF
- Contact Us
Every October, our 200+ grantees from all over the world come together to take part in a conversation about the current landscape of breast cancer research during our annual Symposium and Awards Luncheon.
There’s nothing more important than stopping breast cancer in its tracks. But what people don’t always understand is that, if detected early, breast cancer can often be controlled. It’s when the disease spreads, or metastasizes, that it turns lethal.
This year, we are investing $47 million in annual grants to 222 researchers at leading medical institutions across six continents, making the foundation one of the largest nonprofit funders of breast cancer research in the world.
Earlier this month, a new study about soy made waves in the breast cancer community. With support from BCRF, grantee Dr. Moshe Shike and his coauthors, including Scientific Director Dr.
Last week, BCRF traveled to San Francisco to attend the 2014 Breast Cancer Symposium held by the American Society of Clinical Oncology (ASCO).
BCRF congratulates Dr. Mary-Claire King on her Lasker-Koshland Special Achievement Award in Medical Science.
While breast cancers are known to run in families, they are rarely a direct result of mutated genes inherited from a parent. In fact, inherited, or hereditary, cases account for only 5 - 10 percent of all breast cancers.
Here at BCRF, we have always recognized the need to allow our scientists the freedom and creativity to pursue promising research. It’s the principle we were founded on.